Research Scientist II
Takeda Pharmaceutical Company Limited
Janey Ronxhi is a scientist in the Global DMPK group at Takeda focusing on Bioanalytical/Immunogenicity method development and support for novel biological modalities in pre-clinical studies. She oversees outsourced immunoassays and is responsible for assessing and selecting CROs, method optimization, as well as reviewing and approving bioanalytical reports for both GLP and non-GLP studies. Prior to joining Takeda in 2022, Ronxhi worked at Emulate, Inc. where she led the development and commercialization of Organ-Chip technology. She has given podium presentations at several scientific conferences and has authored/co-authored several publications and patents. Ronxhi earned her Master’s degree at Harvard University, and her Bachelor's degree at Boston University.